Immunotherapy combination promising for untreated patients with advanced melanoma

20 abril 2015

The combination of two immunotherapies for first-line treatment of advanced melanoma induces better responses and far longer progression-free survival than giving one of those drugs alone, new research shows. Further, the combination was effective in the portion of melanoma patients–the majority–who currently have few effective treatment options.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/tt8lg5QAe24/150420084537.htm

Volver